In a recent decision, the Commission expanded the universe of investments that complainants can use to meet the economic prong of the domestic industry requirement.
In a recent order, the ITC reiterated that, unlike in federal courts, only one complainant needs to demonstrate standing at the ITC.
While ITC patent decisions do not have collateral estoppel effects, other ITC decisions, such as trade-secret misappropriation, may create estoppel.
By: Vishal Khatri and Blaney Harper – The U.S. International Trade Commission (“ITC”) terminated Investigation No. 337-TA-1094 based on actual expiration of the asserted patent at issue. Upon a review of the Initial Determination (“ID”), the Commission determined that the ID’s good cause (the imminent expiration of the patent) is moot since the patent is now actually expired.
The ALJ noted that the pending expiration of the ’340 patent is not disputable and the ITC does not have the authority to alter the expiration date.
By: Daniel Kazhdan, Ph.D. and David Maiorana – On February 14, 2018, the Commission affirmed ALJ Pender’s initial determination of non-infringement but based on modified grounds related to the construction of the claim term “single-molecule sequencing.”